Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Translational endpoints in fragile X syndrome.

de Esch CE, Zeidler S, Willemsen R.

Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:256-69. doi: 10.1016/j.neubiorev.2013.10.012. Epub 2013 Oct 30. Review.

PMID:
24184744
2.

Fragile X syndrome: From protein function to therapy.

Bagni C, Oostra BA.

Am J Med Genet A. 2013 Nov;161A(11):2809-21. doi: 10.1002/ajmg.a.36241. Epub 2013 Sep 24. Review.

PMID:
24115651
3.

microRNAs and Fragile X Syndrome.

Lin SL.

Adv Exp Med Biol. 2015;888:107-21. doi: 10.1007/978-3-319-22671-2_7.

PMID:
26663181
4.

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.

Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L, Loring JF, Haggarty SJ.

PLoS One. 2011;6(10):e26203. doi: 10.1371/journal.pone.0026203. Epub 2011 Oct 12.

5.

BDNF in fragile X syndrome.

Castrén ML, Castrén E.

Neuropharmacology. 2014 Jan;76 Pt C:729-36. doi: 10.1016/j.neuropharm.2013.05.018. Epub 2013 May 29. Review.

PMID:
23727436
6.

Frequency of FMR1 gene mutation and CGG repeat polymorphism in intellectually disabled children in Pakistan.

Fatima T, Zaidi SA, Sarfraz N, Perween S, Khurshid F, Imtiaz F.

Am J Med Genet A. 2014 May;164A(5):1151-61. doi: 10.1002/ajmg.a.36423. Epub 2014 Jan 29.

PMID:
24478267
7.

Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention.

Bhogal B, Jongens TA.

Dis Model Mech. 2010 Nov-Dec;3(11-12):693-700. doi: 10.1242/dmm.002006. Epub 2010 Aug 3. Review.

8.

Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.

Zeier Z, Kumar A, Bodhinathan K, Feller JA, Foster TC, Bloom DC.

Gene Ther. 2009 Sep;16(9):1122-9. doi: 10.1038/gt.2009.83. Epub 2009 Jul 2.

9.

Altered structural and functional synaptic plasticity with motor skill learning in a mouse model of fragile X syndrome.

Padmashri R, Reiner BC, Suresh A, Spartz E, Dunaevsky A.

J Neurosci. 2013 Dec 11;33(50):19715-23. doi: 10.1523/JNEUROSCI.2514-13.2013.

10.

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.

Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, Warren ST, Bassell GJ.

J Neurosci. 2010 Aug 11;30(32):10624-38. doi: 10.1523/JNEUROSCI.0402-10.2010.

11.

Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice.

Bostrom CA, Majaess NM, Morch K, White E, Eadie BD, Christie BR.

Cereb Cortex. 2015 Jan;25(1):271-9. doi: 10.1093/cercor/bht237. Epub 2013 Aug 22.

PMID:
23968838
12.

Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model mice.

Renoux AJ, Sala-Hamrick KJ, Carducci NM, Frazer M, Halsey KE, Sutton MA, Dolan DF, Murphy GG, Todd PK.

Behav Brain Res. 2014 Jul 1;267:42-5. doi: 10.1016/j.bbr.2014.03.013. Epub 2014 Mar 19.

13.

Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome.

Yang Q, Yang L, Zhang K, Guo YY, Liu SB, Wu YM, Li XQ, Song Q, Zhuo M, Zhao MG.

Ann Neurol. 2015 Apr;77(4):618-36. doi: 10.1002/ana.24358. Epub 2015 Feb 26.

PMID:
25611593
14.

Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development.

Pop AS, Gomez-Mancilla B, Neri G, Willemsen R, Gasparini F.

Psychopharmacology (Berl). 2014 Mar;231(6):1217-26. Review.

PMID:
24232444
15.

Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.

Lovelace JW, Wen TH, Reinhard S, Hsu MS, Sidhu H, Ethell IM, Binder DK, Razak KA.

Neurobiol Dis. 2016 May;89:126-35. doi: 10.1016/j.nbd.2016.02.002. Epub 2016 Feb 2.

16.

Fragile X Syndrome: from molecular pathology to therapy.

Maurin T, Zongaro S, Bardoni B.

Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:242-55. doi: 10.1016/j.neubiorev.2014.01.006. Epub 2014 Jan 22. Review.

PMID:
24462888
17.

Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.

De Rubeis S, Fernández E, Buzzi A, Di Marino D, Bagni C.

Adv Exp Med Biol. 2012;970:517-51. doi: 10.1007/978-3-7091-0932-8_23. Review.

PMID:
22351071
18.

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Santoro MR, Bray SM, Warren ST.

Annu Rev Pathol. 2012;7:219-45. doi: 10.1146/annurev-pathol-011811-132457. Epub 2011 Oct 10. Review.

PMID:
22017584
19.

Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile X syndrome reveals limited, call type specific deficits.

Roy S, Watkins N, Heck D.

PLoS One. 2012;7(9):e44816. doi: 10.1371/journal.pone.0044816. Epub 2012 Sep 11.

20.

The state of synapses in fragile X syndrome.

Pfeiffer BE, Huber KM.

Neuroscientist. 2009 Oct;15(5):549-67. doi: 10.1177/1073858409333075. Epub 2009 Mar 26. Review.

Supplemental Content

Support Center